April 30, 2012 at 8:00 am Eastern Time

  //health-fitness.news-articles.net/content/2012/04/29/april-30-2012-at-8-00-am-eastern-time.html
  Published in Health and Fitness on Sunday, April 29th 2012 at 10:16 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Haemonetics Changes Timing of Fourth Quarter and Year End Fiscal Year 2012... -- BRAINTREE, Mass., April 29, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about HAE

[ ]

[ Download image ]

BRAINTREE, Mass., April 29, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: [ HAE ]) announced that it will conduct its April 30, 2012 webcast at 8:00 am (EDT), two hours earlier than previously announced.  At that time the Company will discuss its earnings for the fourth quarter and full fiscal year ended March 31, 2012 and guidance for fiscal year 2013, as well as two proposed business acquisitions, all of which are disclosed in separate press releases issued today.  After discussing these topics, management will answer questions.

(Logo: [ http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ] )

Webcast Link: [ http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4702718 ]

Webcast replay will be available from April 30, 2012 after 10:00 am (EDT) until May 7, 2012.

Haemonetics (NYSE: [ HAE ]) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at [ http://www.haemonetics.com ].

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
[ gerry.gould@haemonetics.com ]
Alt. (781) 356-9613

SOURCE Haemonetics Corporation

RELATED LINKS
[ http://www.haemonetics.com ]